NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
MARCH 31, 2022
Note 1 — Description of Organization
and Business Operations
JAWS Hurricane Acquisition
Corporation (the “Company”) was incorporated in Delaware on January 19, 2021. The Company was formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses
(the “Business Combination”).
The Company is not limited
to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging
growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2022, the
Company had not commenced any operations. All activity through March 31, 2022 relates to the Company’s formation and initial public
offering (the “Initial Public Offering”), which is described below, and, since the offering, the search for a prospective
initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business
Combination, at the earliest. The Company generates non-operating income in the form of interest income earned on investments from the
proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared
effective on June 11, 2021. On June 15, 2021, the Company consummated the Initial Public Offering of 27,500,000 units (the “Units”)
with respect to the Class A common stock (the “Class A Common Stock”) included in the Units being offered (the “Public
Shares”) at $10.00 per Unit generating gross proceeds of $275,000,000, which is discussed in Note 4.
Simultaneously with the closing
of the Initial Public Offering, the Company consummated the sale of 3,750,000 warrants (the “Private Placement Warrants”)
at a price of $2.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Hurricane Sponsor, LLC,
generating gross proceeds of $7,500,000, which is described in Note 6.
Offering costs for the Initial
Public Offering amounted to $15,566,551, consisting of $5,500,000 of underwriting fees, $9,625,000 of deferred underwriting
fees payable (which are held in the Trust Account as defined below) and $466,551 of other costs. As described in Note 7, the $9,625,000 of
deferred underwriting fee payable is contingent upon the consummation of a Business Combination by June 14, 2023, subject to the terms
of the underwriting agreement.
Following the closing of
the Initial Public Offering on June 15, 2021, an amount of $316,250,000 ($10.00 per Unit) from the net proceeds of the sale
of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (the “Trust Account”)
and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940,
as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that
holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule
2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and
(ii) the distribution of the Trust Account, as described below.
Simultaneously with the closing
of the Initial Public Offering on June 15, 2021, the Company consummated the closing of the sale of 4,125,000 additional Units
upon receiving notice of the underwriter’s election to fully exercise its overallotment option (the “Overallotment Units”),
generating additional gross proceeds of $41,250,000 and incurring additional offering costs of $2,268,750 in underwriting fees
of which $1,443,750 is deferred until the completion of the Company’s initial Business Combination. Simultaneously with the
exercise of the overallotment, the Company consummated the private placement of an additional 412,500 Private Placement Warrants
to the Sponsor, generating gross proceeds of $825,000.
The Company’s management
has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private
Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business
Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete
one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account
(excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest
in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide
the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of
their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve
the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of
a Business Combination or conduct a tender offer will be made by the Company.
The Public Stockholders will
be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be
$10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).
All of the Public Shares
contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation,
if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain
amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) Topis 480 “Distinguishing Liabilities from Equity”
(“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require Class A Common Stock
subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding
instruments (i.e., Public Warrants as defined in Note 4), the initial carrying value of the Public Shares classified as temporary equity
will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options”. The Public
Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option
to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable
that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of
each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s
net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the balance sheet until such
date that a redemption event takes place.
Redemptions of the Company’s
Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to
the Company’s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed
with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required
by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the
Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation,
conduct the redemptions pursuant to the tender offer rules of the Securities Exchange Commission (“SEC”) and file tender offer
documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by
applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons,
the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender
offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder
Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business
Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective
of whether they vote for or against the proposed transaction
Notwithstanding the foregoing,
the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person
with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate
of 15% or more of the Class A Common Stock sold in the Initial Public Offering, without the prior consent of the Company.
The Company’s Sponsor,
officers and directors (the “Initial Stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation
that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does
not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of
Class A Common Stock in conjunction with any such amendment.
If the Company is unable
to complete a Business Combination by June 14, 2023, 24 months from the closing of the Initial Public Offering (the “Combination
Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible,
but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released
to us to pay the Company’s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided
by the number of then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board
of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law.
The Initial Stockholders
have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination
within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering,
they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete
a Business Combination within the Combination Period.
The underwriters have agreed to waive their rights
to its deferred underwriting commission (see Note 8) held in the Trust Account in the event the Company does not complete a Business Combination
within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of
the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per shares held in
the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and
to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will
not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to
any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent
of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent
registered public accounting firm), prospective target businesses or other entities with which the Company does business execute agreements
waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Emerging Growth Company
The Company is an emerging
growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which
exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison
of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth
company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Liquidity and Capital Resources
As of March 31, 2022, the Company
had $121,018 in cash and a working capital surplus of $115,708. Further, the Company has incurred and expects to continue to incur significant
costs in pursuit of its acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance
with ASU 2014-15, “Disclosures of Uncertainties about an Entity’ Ability to Continue as a Going Concern”, as of
March 31, 2022, the Company does not have sufficient liquidity to meet its current obligations. However, on February 23, 2022, the Company
issued an unsecured promissory note in the principal amount of $500,000 to the Sponsor. The Note does not bear interest and is repayable
in full upon consummation of the Company’s initial business combination. The note is expected to provide the Company liquidity for
the next 12 months. As at March 31, 2022, the Company has borrowed $ 190,137 and can borrow additional amount up to $ 309,863.
Note 2 — Summary of Significant Accounting
Policies
Basis of Presentation
The accompanying unaudited
condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United
States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations
of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete
presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed
financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of
the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements
should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on April 1, 2022. The interim
results for the period presented are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or
for any future interim periods.
Use of Estimates
The preparation of unaudited
condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those
estimates.
Cash and Cash Equivalents
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have
any cash equivalents as of March 31, 2022 and December 31, 2021.
Investments Held in Trust Account
The Company’s portfolio
of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company
Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally
have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised
of U.S. government securities, the investments are classified as trading securities. When the Company's investments held in the Trust
Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money
market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting
from the change in fair value of these securities is included in net gain on investments held in the Trust Account in the accompanying
statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class
A Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A Common Stock subject to mandatory
redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A Common Stock
(including Class A Common Stock that features redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other
times, Class A Common Stock is classified as stockholders’ equity. The Company’s Class A Common Stock features certain redemption
rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly,
at March 31, 2022, and December 31, 2021 31,625,000 shares of Class A Common Stock subject to possible redemption is presented
as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.
The Company recognizes changes
in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value
at the end of each reporting period. Increases or decreases in the carrying amount of the redeemable common stock are affected by charges
against additional paid-in capital and accumulated deficit.
At March 31, 2022, and December 31, 2021 the Class
A common stock reflected in the condensed balance sheets is reconciled in the following table:
Gross proceeds | |
$ | 316,250,000 | |
Less: | |
| | |
Fair value of Public Warrants at issuance | |
| (15,002,435 | ) |
Class A shares offering costs | |
| (17,360,832 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 32,363,267 | |
Class A common stock subject to possible redemption | |
$ | 316,250,000 | |
Offering Costs
Offering costs, including
additional underwriting fees associated with the underwriters’ exercise of the over-allotment option, consist principally of legal,
accounting, underwriting fees and other costs directly related to the Initial Public Offering. Offering costs amounted to $17,860,301.
Of this amount, $17,360,832 was charged to stockholders’ deficit upon the completion of the Initial Public Offering and $499,469 was
expensed due to allocating certain offering costs to the warrant liability.
Concentration of Credit Risk
Financial instruments that
potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times,
may exceed the Federal Deposit Insurance Corporation limit. At March 31, 2022, and December 31, 2021 the Company has not experienced losses
on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial
Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their short-term nature except
for the warrant liability (see Note 8).
Net Income (loss) Per Share
The Company has two classes
of shares, which are referred to as Class A Common Stock (the “Common Stock”) and Class B common stock (the “Founder
Shares”). Earnings and losses are shared pro rata between the two classes of shares. This presentation contemplates a business combination
as the most likely outcome. Public and private warrants to purchase 12,068,750 shares of Common Stock at $11.50 per share
were issued on June 15, 2021. At March 31, 2022, no warrants have been exercised. The 12,068,750 potential shares of Common
Stock for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the period ended
March 31, 2022 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net
income/(loss) per common share is the same as basic net income/(loss) per common share for the period.
For the three months ended March 31, 2022, and for
the period January 19, 2021 (inception) through March 31, 2021, the Company did not have any dilutive securities or other contracts that
could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result,
diluted loss per share is the same as basic loss per share.
The table below presents
a reconciliation of the numerator and denominator used to compute basic and diluted net income/(loss) per share for each class of stock:
For the three months period ended March 31, 2022
| |
Class A | | |
Class B | |
Basic and diluted net income per common share: | |
| | |
| |
Numerator: | |
| | |
| |
Allocation of net income, including accretion of temporary equity | |
$ | 1,949,790 | | |
$ | 487,448 | |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average shares outstanding | |
| 31,625,000 | | |
| 7,906,250 | |
| |
| | | |
| | |
Basic and diluted net income per common share: | |
$ | 0.06 | | |
$ | 0.06 | |
For the period January 19, 2021 (inception)
through March 31, 2021
| |
Class A | | |
Class B | |
Basic and diluted net income per common share: | |
| | |
| |
Numerator: | |
| | |
| |
Allocation of net income, including accretion of temporary equity | |
$ | - | | |
$ | (1,356 | ) |
| |
| | | |
| | |
Denominator: | |
| | | |
| | |
Weighted average shares outstanding | |
| - | | |
| 6,875,000 | |
| |
| | | |
| | |
Basic and diluted net income per common share: | |
$ | - | | |
$ | 0.00 | |
Derivative Warrant Liabilities
The Company accounts for
warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms
and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers
whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480,
and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed
to the Company’s own common shares, among other conditions for equity classification. This assessment, which requires the use of
professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants
are outstanding.
Recent Accounting Standards
Management does not believe that any
recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed
financial statements.
Income Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax
assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or
settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
As of March 31, 2022 and December 31, 2021 the Company had deferred tax assets of $259,272 and $198,671 which had full valuation
allowance against them.
ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022
and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals
or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
The provision for income taxes was deemed to be de minimis for the three months ended March 31, 2022 and the period January 19,
2021 (inception) through March 31, 2021.
Note 3 — Initial Public Offering
Pursuant to the Initial Public
Offering, the Company sold 27,500,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class
A Common Stock (such shares of Class A Common Stock included in the Units being offered, the “Public Shares”), and one-fourth
of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class
A Common Stock at a price of $11.50 per share, subject to adjustment (see Note 8). Simultaneously with the Initial Public Offering,
the underwriters’ exercised their over-allotment option whereby an additional 4,125,000 Units at a price of $10.00 per
Unit under the same terms as those sold in the Initial Public Offering.
Note 4 — Private Placement
Concurrently with the closing
of the Initial Public Offering, the Sponsor purchased an aggregate of 3,750,000 Private Placement Warrants at a price of $2.00 per
Private Placement Warrant for an aggregate purchase price of $7,500,000. Each whole Private Placement Warrant is exercisable for
one whole share of Class A Common Stock at a price of $11.50 per share, subject to adjustment (see Note 8). Concurrently with the
underwriter’s exercise of the over-allotment, the Company consummated a private sale of an additional 412,500 Private
Placement Warrants to the Sponsor at a price of $2.00 per Private Placement Unit generating gross proceeds of $825,000. The proceeds
from the Private Placement Warrants were added to the proceeds from the Initial Public Offering and the underwriter’s exercise of
the over-allotment are held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period,
the Private Placement Warrants will expire worthless.
Note 5 — Related Party Transactions
Founder Shares
On January 19, 2021, the
Sponsor purchased 7,906,250 shares (the “Founder Shares”) of the Company’s Class B Common Stock, par value
$0.0001 (“Class B Common Stock”), for an aggregate price of $25,000. The Founder Shares will automatically convert into
shares of Class A Common Stock at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions,
as described in Note 8. Holders of Founder Shares may also elect to convert their shares of Class B Common Stock into an equal number
of shares of Class A Common Stock, subject to adjustment, at any time.
The Sponsor agreed to forfeit
up to 1,031,250 Founder Shares to the extent that the 45-day over-allotment option was not exercised in full by the underwriters.
Since the underwriters exercised the over-allotment option in full, the Sponsor did not forfeit any Founder Shares.
The Sponsor has agreed, subject
to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of (A) one year after the completion
of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the shares of Class A
common stock equals or exceeds $12.00 per share (as adjusted) for any 20 trading days within any 30-trading day period commencing
at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share
exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of Class A
Common Stock for cash, securities or other property.
Promissory Note – Related Party
On January 19, 2021, the
Company entered into unsecured promissory notes (the “Promissory Notes”) with affiliates of the Sponsor, pursuant to which
the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Notes were non-interest bearing and payable on
the earlier of (i) the completion of the Initial Public Offering or (ii) the date on which the Company determined not to conduct the Initial
Public Offering. The outstanding balance under the Promissory Note of $174,494 was repaid at the closing of the Initial Public Offering
on June 15, 2021.
On February 23, 2022, the
Company issued an unsecured promissory note (the “Note”) in the principal amount of $500,000 to Hurricane Sponsor LLC (the
“Sponsor”). The Note does not bear interest and is repayable in full upon consummation of the Company’s initial business
combination (a “Business Combination”). If the Company does not complete a Business Combination, the Note shall not be repaid,
and all amounts owed under it will be forgiven. Upon the consummation of a Business Combination, the Sponsor shall have the option, but
not the obligation, to convert the principal balance of the Note, in whole or in part, into private placement warrants (as defined in
that certain Warrant Agreement, dated June 15, 2021, by and between the Company and Continental Stock Transfer & Trust Company), at
a price of $2.00 per private placement warrant. The Note is subject to customary events of default, the occurrence of which automatically
trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable.
At March 31, 2022, $190,137 was outstanding under this arrangement.
Related Party Loans
In order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors, may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If
the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event
that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working
Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the
terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The
Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s
discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-business combination entity at
a price of $2.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022 and December 31,
2021, the Company had no outstanding borrowings under the Working Capital Loans.
Administrative Services Fee
The Company entered into
an agreement, commencing on the effective date of the Initial Public Offering through the earlier of the consummation of a Business Combination
and the Company’s liquidation, to pay an affiliate of the Sponsor a monthly fee of $10,000 for office space, secretarial and
administrative services. At March 31, 2022 and December 31, 2021, $30,000 and $66,667, respectively, have been accrued under this arrangement
and included in accounts payable and accrued expenses on the accompanying unaudited condensed balance sheets.
Note 6 — Commitments and Contingencies
Registration Rights
The holders of Founder Shares,
Private Placement Warrants and warrants that may be issued upon conversion of working capital loans, if any, are entitled to registration
rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A Common Stock) pursuant to a registration
rights agreement dated June 15, 2021. These holders are entitled to certain demand and “piggyback” registration rights. However,
the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act
to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear
the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company had granted
the underwriters a 45-day option to purchase up to 4,125,000 additional Units to cover over-allotments at the Initial Public
Offering price less the underwriting discounts and commissions. On June 15, 2021, the underwriters exercised their overallotment option
and purchased 4,125,000 units at a purchase price of $10.00 per unit.
The underwriters were paid
a cash underwriting discount of $0.20 per Unit, or $5,500,000 in the aggregate at the closing of the Initial Public Offering,
and $825,000 in conjunction with the underwriters’ exercise of its overallotment option.
In addition, the underwriters
are entitled to a deferred underwriting commissions of $0.35 per Unit, or $9,625,000 in the aggregate from the closing of the Initial
Public Offering, and $1,443,750 from the underwriters’ exercise of its overallotment option will be payable to the underwriters.
The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes a Business Combination, subject to the terms of the underwriting agreement.
Risks and Uncertainties
Management continues to evaluate
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations, and/or search for a target Company, the specific impact is not readily
determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian
Federation and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including
the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and
related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements. The specific
impact on the Company's financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited
condensed financial statements
Note 7 — Stockholders’ Deficit
Preferred Stock —
The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences
as may be determined from time to time by the Company’s board of directors. As of March 31, 2022, and December 31, 2021 there were
no shares of preferred stock issued or outstanding.
Class A Common Stock —
The Company is authorized to issue 200,000,000 shares of Class A Common Stock with a par value of $0.0001 per share. As
of March 31, 2022, and December 31, 2021 there were no (excluding 31,625,000 shares of Class A Common Stock subject to possible
redemption which are recorded in temporary equity) shares of Class A Common Stock issued and outstanding.
Class B Common Stock —
The Company is authorized to issue 20,000,000 shares of Class B Common Stock with a par value of $0.0001 per share. Holders
of Class B Common Stock are entitled to one vote for each share. As of March 31, 2022, and December 31, 2021 there were 7,906,250 shares
of Class B Common Stock of which none are subject to forfeiture after the underwriters’ exercise of the over-allotment option.
Holders of shares of Class A
Common Stock and shares of Class B Common Stock will vote together as a single class on all other matters submitted to a vote of
stockholders.
The shares of Class B
Common Stock will automatically convert into shares of Class A Common Stock at the time of a Business Combination at a ratio such
that the number of shares of Class A Common Stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on
an as-converted basis, 20% of the sum of (i) the total number of Common Stock issued and outstanding upon completion of the
Initial Public Offering, plus (ii) the total number of shares of Class A Common Stock issued or deemed issued or issuable upon
conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation
to the consummation of a Business Combination, excluding any shares of Class A Common Stock or equity-linked securities exercisable
for or convertible into shares of Class A Common Stock issued, deemed issued, or to be issued, to any seller in a Business Combination
and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the management team upon conversion of Working
Capital Loans. In no event will the shares of Class B Common Stock convert into shares of Class A Common Stock at a rate of
less than one-to-one.
Note 8 — Warrants
At March 31, 2022 and December
31, 2021 there were 7,906,250 Public Warrants and 4,162,500 Private Placement Warrants outstanding. Public Warrants
may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public
Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the
closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier
upon redemption or liquidation.
The Company will not be obligated
to deliver any shares of Class A Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant
exercise unless a registration statement under the Securities Act with respect to the shares of Class A Common Stock underlying the warrants
is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration,
or a valid exemption from registration is available.
No Public Warrant will be
exercisable for cash or on a cashless basis and the Company will not be obligated to issue a share of Class A Common Stock upon exercise
of a warrant unless the share of Class A Common Stock issuable upon such warrant exercise has been registered, qualified, or deemed to
be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as
soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, it will use its commercially
reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class
A Common Stock issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same
to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration
statement and a current prospectus relating to those shares of Class A Common Stock until the warrants expire or are redeemed, as specified
in the warrant agreement; provided that if the shares of Class A Common Stock are at the time of any exercise of a warrant not listed
on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of
the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be
required to file or maintain in effect a registration statement, but the Company will use its commercially reasonable efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering
the shares of Class A Common Stock issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business
Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company
will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with
Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or
qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemptions of warrants when the price per
share of Class A Common Stock equals or exceeds $18.00.
Once the warrants become exercisable, the Company
may call the warrants for redemption (except as described with respect to the Private Placement Warrants):
| ● | in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
| ● | upon a minimum of 30 days’
prior written notice of redemption to each warrant holder; and |
| ● | if, and only if, the closing
price of the shares of Class A Common Stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
The Company will not redeem
the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Class
A Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A Common
Stock is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, the Company may
exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state
securities laws.
Redemption of warrants when the price per share
of Class A Common Stock equals or exceeds $10.00.
Once the warrants become exercisable, the Company
may redeem the outstanding warrants:
| ● | in whole and not in part; |
| ● | at $0.10 per warrant upon a
minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a
cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value”
of the Company’s shares of Class A Common Stock; |
| ● | if, and only if, the closing
price of our shares of Class A Common Stock equals or exceeds $10.00 per public share (as adjusted) for any 20 trading days within
the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
| ● | if the closing price of the
shares of Class A Common Stock for any 20 trading days within a 30-day trading period ending on the third trading day prior to the
date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement
Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
The exercise price and number
of shares of Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event
of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described
below, the Public Warrants will not be adjusted for issuances of Common Stock at a price below its exercise price. Additionally, in no
event will the Company be required to net cash settle the Public Warrants.
If the Company has not completed
a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public
Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s
assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In addition, if (x) the
Company issues additional shares of Class A Common Stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A Common
Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in
the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or
such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds
from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business
Combination on the date of the consummation of a Business Combination (net of redemptions) and (z) the volume weighted average trading
price of its shares of Class A Common Stock during the 20 trading day period starting on the trading day prior to the day on which
the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly
Issued Price, the $18.00 per share redemption trigger price and the “Redemption of Warrants when the price per share of Class A
Common Stock equals or exceeds $10.00” described above will be adjusted (to the nearest cent) to be equal to 180% of the higher
of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest
cent) to be equal to the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price
described above under “Redemption of Warrants when the price per share of Class A Common Stock equals or exceeds $10.00”
will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
The Private Placement Warrants
will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement
Warrants and the shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants will not be transferable,
assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above under “Redemption
of Warrants when the price per share of Class A Common Stock equals or exceeds $10.00,” so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same
basis as the Public Warrants.
The accounting treatment
of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering.
Accordingly, the Company classifies each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds
from the issuance of the Units equal to its fair value determined by a modified Black-Scholes option pricing model. This liability is
subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value,
with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification
at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as
of the date of the event that causes the reclassification.
Note 9 — Fair Value Measurements
The fair value of the Company’s
financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify
assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
|
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
At March 31, 2022, assets
held in the Trust Account were comprised of $1,692 in cash and $316,340,608 in U.S. Treasury Securities.
At December 31, 2021, assets
held in the Trust Account were comprised of $962 in cash and $316,277,563 in U.S. Treasury Securities.
The following table presents
information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and
December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
March 31, 2022
| |
Level | | |
Fair Value | |
Assets: | |
| | |
| |
U.S. Treasury Securities | |
| 1 | | |
$ | 316,342,300 | |
Liabilities: | |
| | | |
| | |
Warrant Liability - Public Warrants | |
| 1 | | |
$ | 5,929,688 | |
Warrant Liability - Private Warrants | |
| 2 | | |
$ | 3,121,875 | |
December 31, 2021
| |
Level | | |
Fair Value | |
Assets: | |
| | |
| |
U.S. Treasury Securities | |
| 1 | | |
$ | 316,277,563 | |
Liabilities: | |
| | | |
| | |
Warrant Liability - Public Warrants | |
| 1 | | |
$ | 7,748,125 | |
Warrant Liability - Private Warrants | |
| 2 | | |
$ | 4,079,250 | |
The Company initially utilized
a Monte Carlo simulation model to value the Public Warrants and Private Placement Warrants at issuance and subsequent reporting dates,
with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liability was determined
using Level 3 inputs. Inherent in a Monte Carlo simulation model are assumptions related to expected share-price volatility, expected
life, risk-free interest rate and dividend yield. The Company estimated the volatility of its common shares based on historical volatility
that matches the expected remaining life of the warrants. The risk-free interest rate was based on the U.S. Treasury zero-coupon yield
curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants was assumed
to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates
to remain at zero.
As of March 31, 2022 and
December 31, 2021, the fair value of the Public Warrants is based on their listed trading price and the fair value of the Private Placement
Warrants is measured using an observable market quote for a similar asset in an active market.
The aforementioned warrant
liabilities are not subject to qualified hedge accounting. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the
reporting period. The Public Warrants began to be separately listed and traded in August 2021 resulting in the transfer of the valuation
of the warrant liabilities from Level 3 measurements to Level 1 for Public Warrants and Level 2 measurements for Private Warrants. As
the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants
having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant
is equivalent to that of each Public Warrant.
For the three months ended March 31, 2022 and for the period January 19, 2021 (inception) through March 31, 2021 there were no changes
in the fair value of the derivative warrant liabilities measured with Level 3 inputs.
Note 10 — Subsequent Events
The Company has evaluated
subsequent events through the date these unaudited condensed financial statements were issued and determined that there were no subsequent
events that would require adjustment or disclosure.